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Abstract
Background: The purpose of this study was to report case series of retinal artery occlusion (RAO) as one of the
significant complication post cardiac intervention.
Case presentation: We are reporting one case of branch RAO and one case of central RAO after percutaneous
coronary intervention (PCI). In case 1, a 74-year-old gentleman with pre-existing diabetes mellitus and hypertension
was electively admitted for PCI for coronary artery disease (CAD) in our centre (UKMMC). Few hours after the
procedure, patient complained of sudden blurring of vision in the right eye. He was found to have branch retinal
artery occlusion. In case 2, a 49-year-old gentleman presented with ST segment elevation myocardial infarction
(STEMI) and had an emergency PCI performed 2 h upon admission. He noticed sudden dropped of vision in his
right eye immediately after the procedure. He was diagnosed to have central retinal artery occlusion.
Conclusions: In conclusion, retinal artery occlusion is a possible complication post PCI. Patients need to be
informed especially in high risk cases.
Keywords: Retinal artery occlusion, Percutaneous coronary intervention, Coronary artery disease, Acute coronary
syndrome, Thromboembolism
Background
Percutaneous coronary intervention (PCI) or coronary
angioplasty is a cardiac procedure to treat a significant
coronary artery disease and as part of revascularisation
to restore coronary artery flow and improved patients
outcome. There are two access routes frequently de-
scribed with regards the procedure: the transfemoral and
transradial approaches. In acute setting, it is a life saving
procedure. However some complications still could not
be avoided [1]. This procedure is currently a standard
procedure for both diagnostic and therapeutic purpose
in management of coronary artery diseases (CAD).
Thromboembolic events are one of its major risks
leading to end organ infarction, especially in the brain,
kidney, and the eyes [1]. One of the possible
thromboembolic events in the eyes is retinal artery occlu-
sion, either branch (BRAO) or central (CRAO), which will
lead to a wide spectrum of visual problems from asymp-
tomatic, partial loss of vision to complete blindness.
Therefore, there should be a high index of suspicion and
immediate attention should be given to any visual disturb-
ance in this group of patients.
To the best of our knowledge, since the introduction of
PCI in 1977, case reports of retinal artery occlusion (CRAO
& BRAO) post-PCI have comprised ten individual case re-
ports from around the world, with the earliest being that in
1985 by Stefansson et al. [2], and the most recent being that
in 2010 by Selton et al. [3]. Herein, we report two cases of
retinal artery occlusion following PCI in our centre. Both
cases were complicated by significant visual morbidity.
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A 74-year-old gentleman with coronary risk factors of
diabetes mellitus and hypertension was electively admit-
ted for PCI for CAD in UKMMC. Diagnostic coronary
angiogram revealed severe CAD with stenosis at the
bifurcation of the artery. Coronary angioplasty was per-
formed using drug-eluting stent (DES) for right coronary
artery (RCA), left main stem coronary artery (LMS) and
left anterior descending artery (LAD). Good angio-
graphic flow was obtained post stents dilatation. On top
of the dual antiplatelet therapy (aspirin and clopidrogrel)
started prior to the procedure, patient was loaded with
clopidrogrel as well during the PCI. Electrocardiogram
(ECG) showed sinus rhythm throughout and after the
procedure. Bedside echocardiography showed good left
ventricular ejection fraction without evidence of clot.
However, immediately after it the patient complained of
loss of vision in his right eye (RE), specifically involving
the lower visual field. Visual acuity in the RE was 6/18
with an inferior visual hemifield defect. Fundus examin-
ation revealed BRAO involving the superior branches of
the retinal artery with the presence of multiple emboli or
Hollenhorst plaque in the branches of the superior retinal
artery (Fig. 1a and b). The superior retina was swollen and
pale (Fig. 1a). Complete neurological examination revealed
no neurological deficit. No carotid bruit detected. ECG
was stable without evidence of arrhythmia. Computed
tomography (CT) scan of the brain was performed and no
abnormalities were detected.
Despite immediate conventional treatment for his
BRAO was given, his RE inferior hemi-field loss was per-
sistent. The condition remained stable and patient was in-
formed for the guarded prognosis for further visual field
recovery. Case was decided to continue on dual antiplate-
let therapy without heparin therapy. He was monitored in
CRW for another 48 h and discharged with stable vital
sign and no evidence of new thromboembolic event.
Dual antiplatelet was continued and planned for life-
long aspirin with one year clopidogrel by his cardiologist
for his underlying treated coronary artery disese.
Case 2
A 49-year-old gentleman with no past medical history
presented to the emergency room of UKMMC with
acute coronary syndrome. He was diagnosed with
STEMI over the anterior leads. Primary PCI was carried
out 2 h after and revealed 60–70 % blockage over the
LAD and left ventricular clots by bedside echocardio-
gram. Angioplasty to LAD was done on the same set-
ting. On day 2 of admission the case was further
complicated with paroxysmal atrial fibrillation (AF)
needed enoxaparin therapy which was converted to war-
farin therapy later.
The patient noted sudden loss of vision in his right eye
immediately after the procedure but unfortunately he was
too fatigued to complain to the treating doctor upon oc-
currence of the symptom. Only on day 6 of admission
when patient was transferred to CRW, ophthalmological
review noted that the patient was nonperceptive to light
(NPL) over the RE with dense relative afferent pupillary
defect (RAPD). There was evidence of CRAO with clas-
sical cherry-red spot in the macula with normal intraocu-
lar pressure. There were also associated with diabetic
retinopathy (DR) changes bilaterally with dots-blots and
flame-shaped haemorrhages which were undiagnosed
prior to admission (Fig. 2a and b). Complete neurological
examination and carotid examination were documented
normal and CT brain showed no significant abnormality.
Due to the severe visual impairment (NPL), carotid
Doppler ultrasound was done 3 weeks post PCI and re-
vealed calcified plaque in the right proximal internal ca-
rotid artery (ICA). Magnetic resonance angiography
(MRA) at 2 months post PCI revealed occlusion of almost
the entire intracranial right ICA. Possible diagnosis of
right ocular ischaemic syndrome (OIS) was also consid-
ered. However, during the acute presentation, there was
no anterior segment involvement (normal IOP) with the
presence of cherry red spot at the macula that denotes the
possibility of preservation of the choroidal circulation dur-
ing the acute setting. Both important features during the
acute presentation were suggestive of CRAO rather than
OIS. However, potentially continuous embolic event to
the ocular blood supply might occur with time due to the
severe stenotic damage involving the carotid artery as fea-
tured on the MRA. This possible continuous embolization
might lead to full-blown ocular ischaemic syndrome. Re-
peat fluorescein angiography might be able to prove these
changes. However it was not performed in this particular
patient as retinal angiogram at this juncture lacks of any
additional clinical therapeutic value. His right eye vision
was NPL and did not improve. Subsequent follow-up
2 months after the PCI, he eventually developed rubeosis
iridis which was treated with laser photocoagulation.
This patient was prescribed by his cardiologist with
triple therapy with lifelong anticoagulant i.e. warfarin
and aspirin and was also on clopidogrel for one month.
Unfortunately patient was defaulted follow up 3 months
post PCI.
Discussion
Coronary angiogram with subsequent PCI is essentially a
non-surgical procedure for diagnosis and treatment of
coronary heart disease. This group of patients commonly
present with stable angina, unstable angina or acute myo-
cardiac infarction either STEMI or NSTEMI. Sometimes
the failure symptoms also warrant this cardiac procedure.
In addition to the underlying thromboembolic risk
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associated with CAD especially with associated
arrhythmia, extension of left main stem artery (LMS),
hypokinetic wall and also the present of intramural
thrombus, PCI also poses a significant risk of embolization
to other parts of the body including the ocular vessels.
Furthermore, the procedure carries a mortality rate of up
to 1.5 % [1].
The incidence of new retinal emboli post-PCI was
6.33 % (19 out of 300 subjects, all asymptomatic) in one
landmark study [4]. The same study also found two con-
ventional risk factors (age and hypertension) and oper-
ator expertise were strongly associated with new retinal
emboli. On the other hand, the mode of the procedure
(type of stent/duration) and severity of CAD had no ef-
fect on the risk of retinal emboli.
In both our cases immediate conventional treatment
was applied due to delayed presentation, which included
prompt ocular massage, reduction of intraocular pres-
sure by intravenous acetazolamide, paracentesis, as well
as carbon dioxide (CO2) rebreathing bag respiration.
However, despite these immediate measures, vision out-
come was poor in the CRAO case and remained un-
changed in the BRAO case. The aim of treatment is
reperfusion of the blocked retinal vessels especially when
it is done within 6 h, since retinal ischemic damage after
240 min is usually irreversible. Reperfusion of blocked
Fig. 1 Case 1: Right eye findings. a Fundus photo showing superior pale retina. b Presence of Hollenhorst plaque in the superotemporal vessel (arrow)
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retinal vessels is believed to be able to reverse or reduce
the damage caused by tissue infarction, only if it is done
within a certain period of time limit, prior to permanent
damage occuring. A study performed in monkeys
showed that CRAO lasting for about 240 min resulted in
massive and irreversible retinal damage [5]. There was
no evidence of damage with CRAO of less than 97 min,
but occlusion within 97–240 min produced a variable
degree of damage.
The conventional treatment methods include ocular
massage; reduction of intraocular pressure by various
medical and surgical means; vasodilation of the CRA by
sublingual isosorbide dinitrate and CO2 rebreathing bag;
antiplatelet and heparin therapy. Other treatments
reported with variable success include isovolemic hemo-
dilution; hyperbaric oxygen; intravenous steroid to re-
duce vascular endothelial; Nd:YAG laser arteriotomy
and embolectomy [6]; surgical embolectomy [7]; and
intraarterial fibrinolysis delivered directly into the oph-
thalmic artery [8]. However, none of these methods are
proven to be effective. Therefore, early diagnosis helps
to identify the source of the problem, thus preventing
further damage or recurrence to other important organ.
Computed tomography (CT) scan of the brain is indi-
cated for the diagnosis of concurrent cerebral vascular
event. This is one of the life threatening thromboembolic
complications that needs to be ruled out. Moreover,
cortical stroke itself can lead to poor vision without
Fig. 2 Case 2: a Right eye fundus showed extensive area of pale retina with cherry red spot. b Left eye fundus showed underlying diabetic
retinopathy changes
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corresponding visual field and fundus changes. CT scan
can help in ruling out these two conditions, either as the
differential diagnosis or concurrent pathology.
Conclusions
In conclusion, CRAO/BRAO is a possible complication
post-PCI. The risk of CRAO/BRAO need to be discussed
especially in high risk cases (ie, severe comorbidities, ad-
vanced age, associated arrhythmia, extension of left main
stem artery (LMS), hypokinetic wall and also the presence
of intramural thrombus). Prompt referral by the cardiolo-
gist and early treatment by ophthalmologists may help pre-
serve or reduce the extent of damage by the occlusion.
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